Literature DB >> 21520202

Updated management of hepatocellular carcinoma.

Gin-Ho Lo.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21520202     DOI： 10.1002/hep.24378

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  The use of transarterial chemoembolization in hepatiocellular carcinoma 2 cm or smaller.

Authors:  Gin-Ho Lo
Journal:  Am J Gastroenterol       Date:  2015-01       Impact factor: 10.864

2.  Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up.

Authors:  Jacopo Desiderio; Stefano Trastulli; Rosario Pasquale; Davide Cavaliere; Roberto Cirocchi; Carlo Boselli; Giuseppe Noya; Amilcare Parisi
Journal:  Langenbecks Arch Surg       Date:  2012-12-07       Impact factor: 3.445

Review 3.  Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.

Authors:  Jiyao Sheng; Hanjiao Qin; Kun Zhang; Bingjin Li; Xuewen Zhang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway.

Authors:  Lu Huang; Qiong Yang; Huihong Chen; Zhenggeng Wang; Qi Liu; Shuhua Ai
Journal:  Open Med (Wars)       Date:  2022-04-01

5.  Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk.

Authors:  Jiyao Sheng; Luyan Shen; Liankun Sun; Xuewen Zhang; Ranji Cui; Lizhong Wang
Journal:  Cell Prolif       Date:  2019-04-29       Impact factor: 6.831

6.  Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells.

Authors:  Zhu-Ting Fang; Guang-Zhi Wang; Wei Zhang; Xu-Dong Qu; Rong Liu; Sheng Qian; Liang Zhu; Bo Zhou; Jian-Hua Wang
Journal:  Onco Targets Ther       Date:  2013-11-05       Impact factor: 4.147

7.  Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma.

Authors:  Li Huang; Zhuning Mo; Zuojian Hu; Linyan Zhang; Shanzi Qin; Xue Qin; Shan Li
Journal:  Cancer Cell Int       Date:  2020-03-12       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.